Skip to main content

Radiotherapy for Cutaneous Angiosarcoma

  • Chapter
  • First Online:
Radiation Therapy for Skin Cancer

Abstract

Cutaneous angiosarcoma (AS) is a rare, aggressive malignancy with a poor prognosis. It usually arises on the scalp or face and is locally advanced at presentation. Patients are most often white, male, and elderly. A subset of patients present with multifocal disease and/or positive regional nodes. Another group of patients who may present with AS are patients treated with a partial mastectomy and radiotherapy (RT) for breast cancer. Although the optimal treatment is surgery followed by wide-field RT, the disease is sometimes so extensive at diagnosis that it is not completely resectable. Even after optimal local-regional treatment, there is a relatively high likelihood of a local recurrence at the margins of the RT fields. The probability of hematogenous dissemination is relatively high. Limited data suggest that chemotherapy may be useful for palliation with progression-free survival rates ranging from 1 to 5 months. Depending on primary site, the 5-year local-regional control rates are approximately 40–50 %, the 5-year distant metastasis-free survival rates range from 20 to 40 %, and the 5-year survival rates range from 10 to 30 %. AS arising on the scalp has the worst prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hodgkinson DJ, Soule EH, Woods JE. Cutaneous angiosarcoma of the head and neck. Cancer. 1979;44(3):1106–13.

    Article  PubMed  CAS  Google Scholar 

  2. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59(5):1046–57.

    Article  PubMed  CAS  Google Scholar 

  3. Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, et al. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys. 2002;52(4):1032–40.

    Article  PubMed  Google Scholar 

  4. Ward JR, Feigenberg SJ, Mendenhall NP, Marcus Jr RB, Mendenhall WM. Radiation therapy for angiosarcoma. Head Neck. 2003;25(10):873–8.

    Article  PubMed  Google Scholar 

  5. Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003;98(8):1716–26.

    Article  PubMed  Google Scholar 

  6. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77(11):2400–6.

    Article  PubMed  CAS  Google Scholar 

  7. Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11(3):241–7.

    Article  PubMed  Google Scholar 

  8. Palta M, Morris CG, Grobmyer SR, Copeland III EM, Mendenhall NP. Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer. 2010;116(8):1872–8.

    Article  PubMed  Google Scholar 

  9. Schmid H, Zietz C. Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literature. Pathology. 2005;37(4):284–7.

    Article  PubMed  Google Scholar 

  10. Zietz C, Rumpler U, Sturzl M, Lohrs U. Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack. Am J Pathol. 2001;159(3):963–70.

    Article  PubMed  CAS  Google Scholar 

  11. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients. Br J Dermatol. 2004;150(1):160–1.

    Article  PubMed  CAS  Google Scholar 

  12. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Observations on angiopoietin 2 in patients with angiosarcoma. Br J Dermatol. 2004;150(5):1028–9.

    Article  PubMed  CAS  Google Scholar 

  13. Isoda H, Imai M, Inagawa S, Miura K, Sakahara H. Magnetic resonance imaging findings of angiosarcoma of the scalp. J Comput Assist Tomogr. 2005;29(6):858–62.

    Article  PubMed  Google Scholar 

  14. Klijanienko J, Caillaud JM, Lagace R, Vielh P. Cytohistologic correlations in angiosarcoma including classic and epithelioid variants: Institut Curie’s experience. Diagn Cytopathol. 2003;29(3):140–5.

    Article  PubMed  Google Scholar 

  15. American Joint Committee on Cancer, editor. Soft tissue sarcoma. AJCC Cancer Staging Manual. New York, NY: Springer; 2002. p. 193–200.

    Google Scholar 

  16. Scott MT, Portnow LH, Morris CG, Marcus RB, Jr., Mendenhall NP, Mendenhall WM, et al. Radiation therapy for angiosarcoma: the 35-year University of Florida experience. Am J Clin Oncol. 2012;36(2):174–80.

    Google Scholar 

  17. Isogai R, Kawada A, Aragane Y, Tezuka T. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol. 2004;31(4):335–41.

    PubMed  Google Scholar 

  18. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol. 2005;19(3):357–9.

    Article  PubMed  CAS  Google Scholar 

  19. Wollina U, Fuller J, Graefe T, Kaatz M, Lopatta E. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol. 2001;127(6):396–9.

    Article  PubMed  CAS  Google Scholar 

  20. Bong AB, Bonnekoh B, Schon MP, Gollnick H. Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa. J Am Acad Dermatol. 2005;52(2 Suppl 1):20–3.

    Article  PubMed  Google Scholar 

  21. Eiling S, Lischner S, Busch JO, Rothaupt D, Christophers E, Hauschild A. Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol. 2002;147(1):150–3.

    Article  PubMed  CAS  Google Scholar 

  22. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104(2):361–6.

    Article  PubMed  CAS  Google Scholar 

  23. Yamada M, Hatta N, Mizuno M, Oishi N, Takehara K. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head. Br J Dermatol. 2005;152(4):811–2.

    Article  PubMed  CAS  Google Scholar 

  24. Morrison WH, Byers RM, Garden AS, Evans HL, Ang KK, Peters LJ. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer. 1995;76(2):319–27.

    Article  PubMed  CAS  Google Scholar 

  25. Tung SS, Shiu AS, Starkschall G, Morrison WH, Hogstrom KR. Dosimetric evaluation of total scalp irradiation using a lateral electron-photon technique. Int J Radiat Oncol Biol Phys. 1993;27(1):153–60.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William M. Mendenhall .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mendenhall, W.M., Mendenhall, N.P. (2013). Radiotherapy for Cutaneous Angiosarcoma. In: Cognetta Jr., A., Mendenhall, W. (eds) Radiation Therapy for Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6986-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6986-5_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6985-8

  • Online ISBN: 978-1-4614-6986-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics